NCT04403490

Brief Summary

There is strong evidence that recent intensive interventions based on motor skill learning principles are efficient on functional and neuroplastic changes of children with cerebral palsy (CP). Besides, impaired selective voluntary motor control (SVMC) is one of four interrelated neuromuscular deficits in children with CP and is listed in the ICF-CY (International Classification of Functioning, Disability and Health for Children and Youth) under body functions. Additionally, impaired SVMC has been shown to negatively affect the motor and functional abilities of children with CP. However, there have been little scientific investigations on the trainability of SVMC according to therapeutic interventions. Therefore, the study aims to evaluate the effect of Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) on the body function and structures of children with bilateral and unilateral cerebral palsy, including SVMC and brain structure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

May 26, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 27, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

June 15, 2022

Status Verified

June 1, 2022

Enrollment Period

2.5 years

First QC Date

May 20, 2020

Last Update Submit

June 14, 2022

Conditions

Keywords

motor skill learningbody functionbody structureselective voluntary motor controlbrain structureneuroplasticityintensive therapycerebral palsy

Outcome Measures

Primary Outcomes (5)

  • Changes in Diffusion Tensor Imaging (DTI)

    This sequence allows to measure changes in the fractional anisotropy (FA) on the white matter tracts. FA is a scalar value (no unit) between zero and one that describes the degree of anisotropy of white matter water molecules.

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in Test of Arm Selective Control (TASC)

    The TASC is an upper limb selective motor control evaluation tool including eight motions in each arm and up to three attempts are allowed for each motion. This assessment tool was developed in 2010 and Sukal-Moulton et al. have proved its validity and reliability for children with CP in 2017. After completion of the best attempt, points ranging from 0 (absent), 1 (impaired) to 2 (normal) are recorded for each joint depending on the movement properties and descriptors of the test.

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in Selective Control Assessment of the Lower Extremity (SCALE):

    The SCALE was designed to evaluate lower limb selective motor control of children with cerebral palsy. The SCALE includes testing of five reciprocal lower extremity movements. SVMC is graded at each joint as 'Normal' (2 points), 'Impaired' (1 point), or 'Unable' (0 points).

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in Strength

    The strength will be measured for main muscle groups using a Microfet.

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in Stiffness

    The stiffness will be measured using a device developed and already validated at UCLouvain.

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

Secondary Outcomes (25)

  • Changes in Assisting Hand Assessment (AHA or BoHA)

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in ABILHAND-Kids Questionnaire

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in ACTIVLIM-CP Questionnaire

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in Gross Motor Function Measurement (GMFM 66)

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • Changes in 6 Minutes Walking Test (6MWT)

    pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  • +20 more secondary outcomes

Study Arms (2)

HABIT-ILE

EXPERIMENTAL

Hand and arm bimanual intensive therapy including lower extremities

Behavioral: HABIT-ILE

Conventional intervention

ACTIVE COMPARATOR

Conventional physical and occupational therapy

Behavioral: Conventional intervention

Interventions

HABIT-ILEBEHAVIORAL

2 weeks HABIT-ILE

HABIT-ILE

2 weeks usual intervention (waitlist group)

Conventional intervention

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosed bilateral and unilateral cerebral palsy,
  • MACS levels from I to IV,
  • GMFCS levels from I to IV,
  • Ability to follow instructions and complete testing.

You may not qualify if:

  • Orthopedic surgery, botulinum toxin injections or another unusual intervention less than 6 months before or within the study period.
  • Unstable seizure
  • Severe visual or cognitive impairments likely to interfere with intervention or testing session completion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Neuroscience, UCLouvain

Brussels, 1200, Belgium

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Yannick Bleyenheuft

    Institute of Neuroscience, UCLouvain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yannick Bleyenheuft, Professor

CONTACT

Seyma Kilcioglu, PhD Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 20, 2020

First Posted

May 27, 2020

Study Start

May 26, 2020

Primary Completion

November 20, 2022

Study Completion

December 20, 2022

Last Updated

June 15, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations